39 related articles for article (PubMed ID: 23023138)
1. Distribution of human papillomavirus (HPV) genotypes detected by routine pap smear in Uyghur-Muslim women from Karasay Township Hotan (Xinjiang, China).
Mijit F; Ablimit T; Abduxkur G; Abliz G
J Med Virol; 2015 Nov; 87(11):1960-5. PubMed ID: 26081269
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening.
Cho EH; Park MS; Woo HY; Park H; Kwon MJ
J Gynecol Oncol; 2024 Mar; ():. PubMed ID: 38522949
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Management of Oncogenic HPV Cervical Infections: The Field Experience in Wuxi, China.
Liu Y; Yin Y; Zhang Y; Lin L; Zhao M; Chen Q
Front Med (Lausanne); 2022; 9():825228. PubMed ID: 35402444
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pap Smear: Validation of HPV Genotype and Host Methylation Profiles of
Shen-Gunther J; Xia Q; Stacey W; Asusta HB
Front Microbiol; 2020; 11():595902. PubMed ID: 33178175
[TBL] [Abstract][Full Text] [Related]
5. Can HPV Test on Random Urine Replace Self-HPV Test on Vaginal Self-Samples or Clinician-Collected Cervical Samples?
Shih YH; Sun L; Hsu ST; Chen MJ; Lu CH
Int J Womens Health; 2023; 15():1421-1429. PubMed ID: 37719784
[TBL] [Abstract][Full Text] [Related]
6. False positive cervical HPV screening test results.
Schiffman M; de Sanjose S
Papillomavirus Res; 2019 Jun; 7():184-187. PubMed ID: 31029852
[TBL] [Abstract][Full Text] [Related]
7. 2023 global inventory of commercial molecular tests for human papillomaviruses (HPV).
Poljak M; Oštrbenk Valenčak A; Cuschieri K; Bohinc KB; Arbyn M
J Clin Virol; 2024 Jun; 172():105671. PubMed ID: 38518504
[TBL] [Abstract][Full Text] [Related]
8. Application of CytoPath®Easy Vials in Cervical Cancer Screening: Self-Sampling Approach.
Fernandes SPM; Vilarinho AS; Frutuoso A; Teixeira C; Silva RAAP
J Cytol; 2024; 41(2):67-74. PubMed ID: 38779609
[TBL] [Abstract][Full Text] [Related]
9. A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30years.
Rebolj M; Bonde J; Ejegod D; Preisler S; Rygaard C; Lynge E
Eur J Cancer; 2015 Jul; 51(11):1456-66. PubMed ID: 25979832
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy.
Einstein MH; Smith KM; Davis TE; Schmeler KM; Ferris DG; Savage AH; Gray JE; Stoler MH; Wright TC; Ferenczy A; Castle PE
J Clin Microbiol; 2014 Jun; 52(6):2089-95. PubMed ID: 24719440
[TBL] [Abstract][Full Text] [Related]
11. Comparing the performance of six human papillomavirus tests in a screening population.
Cuzick J; Cadman L; Mesher D; Austin J; Ashdown-Barr L; Ho L; Terry G; Liddle S; Wright C; Lyons D; Szarewski A
Br J Cancer; 2013 Mar; 108(4):908-13. PubMed ID: 23370211
[TBL] [Abstract][Full Text] [Related]
12. Cervista HPV HR test for cervical cancer screening: a comparative study in the Catalonian population.
Alameda F; Garrote L; Mojal S; Sousa C; Muset M; LLoveras B; Bellosillo B; Saldanha C; Carreras R; Serrano S
Arch Pathol Lab Med; 2015 Feb; 139(2):241-4. PubMed ID: 25611107
[TBL] [Abstract][Full Text] [Related]
13. Cancer screening and prevention in low-resource settings.
Shastri A; Shastri SS
Nat Rev Cancer; 2014 Dec; 14(12):822-9. PubMed ID: 25355377
[TBL] [Abstract][Full Text] [Related]
14. Clinical validation of the Cervista HPV HR test according to the international guidelines for human papillomavirus test requirements for cervical cancer screening.
Boers A; Wang R; Slagter-Menkema L; van Hemel BM; Ghyssaert H; van der Zee AG; Wisman GB; Schuuring E
J Clin Microbiol; 2014 Dec; 52(12):4391-3. PubMed ID: 25297324
[TBL] [Abstract][Full Text] [Related]
15. Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-off.
Boers A; Slagter-Menkema L; van Hemel BM; Belinson JL; Ruitenbeek T; Buikema HJ; Klip H; Ghyssaert H; van der Zee AG; de Bock GH; Wisman GB; Schuuring E
PLoS One; 2014; 9(7):e101930. PubMed ID: 25051098
[TBL] [Abstract][Full Text] [Related]
16. Clinical performance characteristics of the Cervista HPV HR test kit in cervical cancer screening in China.
Zhao J; Zhang X; Ma J; Liu G; Yao D; Zhang W; Wang J; Wei L; Zhao Y; Zeng Y; Liao Q
J Low Genit Tract Dis; 2012 Oct; 16(4):358-63. PubMed ID: 23023138
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of The Cervista HPV A9 group In Screening Patients for Cervical Cancer.
Zhao J; Du H; Belinson JL; Qu X; Zhang W; Mei J; Yang B; Wang C; Zhang L; Wu R
J Med Screen; 2016 Mar; 23(1):38-43. PubMed ID: 26466824
[TBL] [Abstract][Full Text] [Related]
18. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
19. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
